UNSPSC 41141910: Alanine amino transferase (alt/sgpt) test system

In this classification, Alanine amino transferase (alt/sgpt) test system connotes a device used to measure Alanine amino transferase (alt/sgpt) levels. US FDA regulates Alanine amino transferase (alt/sgpt) test system under 21 CFR 862.1030 and under FDA product code CKA.

UNSPSC 41141910 Alanine amino transferase (alt/sgpt) test system is a Commodity code describing laboratory diagnostic testing kits and reagent systems used in forensic and clinical analysis by state and local public health, law enforcement, and correctional agencies. The code captures direct ELISA testing kits, immunoanalysis reagents, DNA screening kits, certified reference standards, and mass spectrometry equipment that state and local laboratories procure for substance analysis, toxicology, seized drug analysis, and method validation in forensic settings. Issuing bodies include state health departments, state law enforcement agencies, county forensic laboratories, state correctional departments, and regional public safety crime labs. Recent solicitations show state departments of public safety, state health services commissions, county forensic facilities, and state correctional systems as repeat buyers under this code, each operating dedicated laboratory analysis operations requiring qualified reagents and analytical equipment to support drug screening, evidentiary analysis, and laboratory accreditation compliance.

Activity under this code concentrates in Texas and Florida, with recent opportunities spanning the Texas Department of Public Safety Crime Lab Division, Texas Health and Human Services Commission on behalf of the Department of State Health Services, Texas Department of Criminal Justice, Pinellas County Forensic Laboratory in partnership with the Florida Department of Law Enforcement, and the Illinois Department of Financial and Professional Regulation's Centralized Maintenance Services. The Texas DPS issued IFB 405-26R0008445A on July 9, 2026, requesting Direct ELISA testing kits for substance analysis—cannabinoids, opiates, PCP, amphetamines, barbiturates, and related compounds—with bids due July 23, 2026. The Texas HHSC issued IFB HHS0016902v2 for QIAxcel and QIAamp DNA screening kits with a January 29, 2026, response date and estimated FY2025 historical value between $25,050.00 and $30,000.00. Pinellas County, Florida, procured certified drug reference standards through ITQ 26-0305-ITQ in April 2026, with approximately $49,034.00 in federal funding from the Paul Coverdell Forensic Sciences Improvement Act Program designated for equipment and supplies. These opportunities require compliance with ISO/IEC 17025:2017 and ISO 17034:2016 accreditation standards, firm pricing for stated contract terms, and in some cases HUB subcontracting plans or SBE preferences where applicable.